TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation

Specific immunotherapy (SIT) is the only specific remedy for the treatment of allergic diseases currently. B cells are important immune cells in the immunity. The role of B cells in immune regulatory activities has not been fully understood yet. This study aims to elucidate the role of the thrombosp...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 3; no. 1; p. 3345
Main Authors Zhang, Huan-Ping, Wu, Yingying, Liu, Jiangqi, Jiang, Jing, Geng, Xiao-Rui, Yang, Gui, Mo, Lihua, Liu, Zhi-Qiang, Liu, Zhi-Gang, Yang, Ping-Chang
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 26.11.2013
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Specific immunotherapy (SIT) is the only specific remedy for the treatment of allergic diseases currently. B cells are important immune cells in the immunity. The role of B cells in immune regulatory activities has not been fully understood yet. This study aims to elucidate the role of the thrombospondin (TSP)1-producing B cells in the immune regulatory role of SIT. The results showed that after SIT, the frequency of CD35 + B cells was increased in the intestine of mice with food allergy. The CD35 + B cells expressed TSP1 after exposure to specific antigens. Co-culture with the TSP1-producing CD35 + B cells decreased the levels of CD80/CD86 in dendritic cells; the cells convert naïve CD4 + T cells to regulatory T cells to inhibit allergic inflammation in the intestine.
ISSN:2045-2322
2045-2322
DOI:10.1038/srep03345